NPI-002

N/A

Report date: 2025/05/14 15:50:00

Base Information

Drug NameNPI-002
Drug Alias NameNPI-002NPI 002
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionC5a anaphylatoxin chemotactic receptor 1 antagonists
TargetsC5a anaphylatoxin chemotactic receptor 1
Therapy Area/IndicationsCataract
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesNacuity Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesNacuity Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsCataract
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A